Assessing Fall Risk Using Transcranial Magnetic Stimulation and Quantitative Sensory Testing

September 21, 2025 updated by: Chulalongkorn University

Development of Artificial Intelligence Innovation for Assessing Fall Risk Using Clinical Neurological Studies With Transcranial Magnetic Stimulation and Quantitative Sensory Testing in the Thai Elderly

The elderly are at high risk of falls due to neurophysiological changes, such as motor and sensory impairment, that occur with aging. The incidence of falls in older adults is high, with approximately 30% of adults over the age of 65 falling at least once per year. Falls can lead to serious consequences such as fractures, hospitalization, and loss of independence. The changes in neurophysiology have also been found to decrease balance control in aging people, leading to postural instability. It is well-known that postural balance is influenced by sensory inputs, including touch, proprioception, vision, and vestibular, as well as motor output such as motor controls. Impairments in these systems contribute to postural instability and an increased risk of falling in the elderly.

Study Overview

Status

Completed

Conditions

Detailed Description

The data collection will be arranged in the same order. Practice trials will be provided before the start of the data collection. The entire data collection session will take approximately 90 minutes. Data collection will be conducted for both the baseline and the 3-month follow-up.

The data collection will include:

  1. Demographic information such as age, sex, body height, body weight, body mass index, medical history, medical diagnosis, body composition, and the MoCA (Montreal Cognitive Assessment).
  2. Neurophysiological assessments such as electromyography and Quantitative Sensory Testing (QST).
  3. Functional tests such as the Timed up and go test and Chait stand test.

Study Type

Observational

Enrollment (Actual)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bangkok, Thailand, 10330
        • Department of Medicine, Faculty of Medicine, Chulalongkorn University.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Thai elderly who have received check-ups or treatment at King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

Description

Inclusion Criteria:

1) Male and female individuals aged 65-80 years.

Exclusion Criteria:

  1. History of previous lower limb surgery, such as total knee replacement or ankle surgery.
  2. History of a neurological disorder, such as stroke or Parkinson's disease.
  3. History of vestibular disease, such as Meniere's disease.
  4. History of seizures or epilepsy.
  5. The presence of metal implanted devices in or around the head area
  6. MoCA score < 26

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Non-fallers
Elderly without history of fall
Fallers-low risk
Elderly with a history of falling 1 time within the last year.
Fallers-moderate risk
Elderly with a history of falling twice within the last year.
Fallers-high risk
Elderly with a history of falling >2 times within the last year.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Montreal Cognitive Assessment (MoCA)
Time Frame: MoCA will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

MoCa is a screening test used to detect mild cognitive decline and early signs of dementia. The total score of the test is 30 points.

The MoCA will be recored in scores.

MoCA will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.
Body weight
Time Frame: Body weight will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

We will used the bioelectrical impedance analysis (BIA), which is a method used for measuring body composition.Participants will be asked to step on to the BIA device, placing their feet on the foot electrodes.

The body weight will be recored in kilograms.

Body weight will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.
Muscle mass
Time Frame: Muscle mass will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

We will used the bioelectrical impedance analysis (BIA), which is a method used for measuring body composition.Participants will be asked to step on to the BIA device, placing their feet on the foot electrodes.

The muscle mass will be recored in kilograms.

Muscle mass will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.
Body mass index (BMI)
Time Frame: BMI will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

We will used the bioelectrical impedance analysis (BIA), which is a method used for measuring body composition.Participants will be asked to step on to the BIA device, placing their feet on the foot electrodes.

The BMI will be recored in kg/m^2.

BMI will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.
Percent body fat
Time Frame: Percent body fat will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

We will used the bioelectrical impedance analysis (BIA), which is a method used for measuring body composition.Participants will be asked to step on to the BIA device, placing their feet on the foot electrodes.

Percent body fat will be recored in percentage.

Percent body fat will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.
The duration during Timed Up and Go Test
Time Frame: TUG will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

The Timed Up and Go Test (TUG) is a test for assessing fall risk. Participants will begin by sitting on a chair. They will be asked to stand up, walk 3 meters away at a comfortable speed, turn around a traffic cone, walk back, and sit down.

TUG will be recored in second.

TUG will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.
The repetition of Chair Stand Test
Time Frame: Chair Stand Test will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

Chair Stand Test is used to test leg strength and endurance. Participants will begin by sitting on a chair. Participants will be instructed to stand up with full leg extension as quickly as possible, sit back down as quickly as possible, andrepeat this process for 30 seconds.

Chair Stand Test will be recorded in repetition.

Chair Stand Test will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.
Muscle evoke potential (MEP)
Time Frame: Muscle evoke potential will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

Participants will be stimulated at the primary motor cortex by transcranial magnetic stimulation to measure cortical excitability, which sends the motor outputs to Tibialis Anterior (TA) and Abductor Pollicis Brevis (APB) muscles. The MEP will be used to assess muscle activity in these muscles during the stimulation.

The MEP will be measured in mV.

Muscle evoke potential will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.
Cortical silent period (CSP)
Time Frame: Muscle evoke potential will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

Participants will be stimulated at the primary motor cortex by transcranial magnetic stimulation to measure cortical excitability, which sends the motor outputs to Tibialis Anterior (TA) and Abductor Pollicis Brevis (APB) muscles. The CSP will be used to assess muscle activity in these muscles during the stimulation.

The CSP will be measured in ms.

Muscle evoke potential will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.
Cold temperature threshold
Time Frame: Cold temperature threshold will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

Participants will be stimulated by Quantitative Sensory Testing (QST) with cold temperature on their legs. QST is the standard device validated by the manufacturer and approved for use in research assessments, as demonstrated in the supplementary files.

Cold temperature threshold will be measure in degree Celsius.

Cold temperature threshold will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.
Vibration threshold
Time Frame: Vibration temperature threshold will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

Participants will be stimulated by Quantitative Sensory Testing (QST) with vibration threshold on their legs. QST is the standard device validated by the manufacturer and approved for use in research assessments, as demonstrated in the supplementary files.

Vibration threshold will be measure in μm.

Vibration temperature threshold will be measured at two time points (baseline and 3 months), through study completion, an average of 1 year.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jakkrit Amornvit, MD, Chulalongkorn University
  • Principal Investigator: Phunsuk Kantha, PT.,PhD, Mahidol University
  • Principal Investigator: Kulvara Lapanan, PT, Chulalongkorn University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 16, 2024

Primary Completion (Actual)

May 16, 2025

Study Completion (Actual)

August 16, 2025

Study Registration Dates

First Submitted

June 13, 2024

First Submitted That Met QC Criteria

June 24, 2024

First Posted (Actual)

June 28, 2024

Study Record Updates

Last Update Posted (Estimated)

September 25, 2025

Last Update Submitted That Met QC Criteria

September 21, 2025

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • COA No. 0607/2024

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fall

Subscribe